We're still in the throes of transitioning away from a majority of combustion engine-powered vehicles globally, which means ...
Mepolizumab significantly reduced asthma exacerbations and oral corticosteroid use in patients with SEA, with or without CRSwNP, in a real-world setting. Improvements in lung function and asthma ...
In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...
Real-world, 12-month results demonstrated efficacy, safety and durability for faricimab as a treatment for retinal vein ...
Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...
Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...
Brentuximab vedotin with CHP is effective and safe for first-line PTCL treatment, achieving an 80% overall response rate. Median progression-free survival was 39.7 months, with a 1-year overall ...
Sensitive skin affects up to 70% of people globally – a figure that has risen by 68% over the past two decades – yet it remains widely overlooked and under-studied. 2,3 As more people live fast-paced ...
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...
When asked about food allergy management, more individuals reported choosing allergen avoidance over oral immunotherapy or ...
Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback